Staining Principles and Methods for Cell Death, Proliferation, and Metabolic Viability
Staining Principles and Methods for Cell Death, Proliferation, and Metabolic Viability
Under conditions such as drug exposure, nutrient limitation, oxidative stress, inflammatory/immune effects, and mechanical or osmotic perturbations, cell populations often exhibit concurrent declines in viability, shifts in cell death pathways, and remodeling of cell-cycle kinetics. Importantly, “metabolic viability,” “cell number,” and “proliferative progression” are not equivalent in either biological meaning or experimental readouts. Therefore, it is advisable to perform parallel, cross-validated measurements along three relatively independent axes: membrane-associated events (phosphatidylserine externalization and membrane integrity), DNA synthesis events (EdU incorporation), and metabolic reduction events (tetrazolium/TTC colorimetric readouts), to obtain more interpretable quantitative assessments of cellular state.
I. Apoptosis and Live/Dead Discrimination Staining
Under conditions such as drug perturbation, nutrient deprivation, oxidative stress, and immune attack, cells may undergo apoptosis or necrosis. Accordingly, determining cell-death type and survival fraction is a foundational step in cell biology, oncology and pharmacodynamics evaluation, toxicology screening, and culture quality control. These staining systems are typically constructed around two canonical biological events: (i) early apoptotic externalization of phosphatidylserine (PS) on the plasma membrane, which can be recognized by Annexin V; and (ii) loss of plasma-membrane integrity, which permits nucleic-acid dyes (e.g., PI, 7-AAD, DAPI) to enter cells and bind DNA, thereby indicating late apoptosis/necrosis. When paired with flow cytometry or fluorescence microscopy imaging, this framework enables rapid discrimination of live versus dead cells and supports basic staging of apoptotic progression.
【Principle】
(1) During early apoptosis, disruption of plasma-membrane phospholipid asymmetry occurs, and phosphatidylserine (PS) flips from the cytosolic leaflet to the extracellular leaflet; under Ca²⁺-dependent conditions, Annexin V binds externalized PS, thereby labeling early apoptosis–associated membrane events.
(2) As apoptosis progresses or necrosis occurs, plasma-membrane barrier function declines; nucleic acid–binding dyes such as PI, 7-AAD, and DAPI can enter cells and bind nucleic acids to generate fluorescent signals, indicating compromised membrane integrity.
(3) Joint analysis of Annexin V signals and membrane-impermeant dye signals enables classification of cell populations into subgroups such as viable, early apoptotic, late apoptotic/secondary necrotic, and primary necrotic (or severe membrane-damage) fractions, supporting phenotypic interpretation of death processes.
(4) This detection framework is compatible with flow cytometry and fluorescence microscopy platforms, enabling single-cell–level proportion statistics, phenotypic classification, and observation of spatial distributions.
【Advantages】
(1) Compared with a single live/dead stain, this combination provides layered information on apoptotic progression, improving resolution for death-type assignment and interpretation of treatment effects.
(2) Single-cell resolution supports population-structure analysis in heterogeneous samples and quantitative comparison across multiple treatment conditions.
(3) Methodology is mature, with generally good experimental reproducibility and cross-batch comparability, and can be configured across multiple fluorescence channels to accommodate multicolor experimental designs.
(4) Applicable to pharmacodynamic evaluation, toxicology screening, immune cell–mediated cytotoxicity assessment, and cell culture quality control, among other use cases.
【Limitations and Notes】
(1) Sample collection and handling perturbations can introduce nonspecific membrane damage, elevating membrane-impermeant dye signals and blurring phenotyping boundaries; collection intensity and centrifugation conditions should be stringently controlled.
(2) Annexin V–PS binding is sensitive to the Ca²⁺ environment; inappropriate ionic composition of buffers or residual chelators may weaken or shift signals.
(3) Membrane-impermeant dye readouts are time dependent; delays between staining and acquisition can systematically bias subgroup proportions, requiring standardization of the staining-to-measurement time window.
(4) Annexin V positivity reflects the membrane event of PS externalization and is not equivalent to an irreversible death outcome; mechanistic interpretation should incorporate time-course design and additional functional/structural endpoints.
【Aladdin-related Products】
Catalog No. | Product Name | Grade and Purity | Applications |
7-AAD Viability Staining Solution | sterile-filtered, Suitable for Immunofluorescence(IF), BioReagent, ready-to-use, Biological Stain, for fluorescence analysis, Biological dye grade, for microscopy, for cell culture, sterile, 0.1 mg/mL, 2.5μL/test | Live/dead (viability) staining; flow cytometry or fluorescence microscopy imaging to exclude dead cells; apoptosis analysis in combination with Annexin V | |
AO/PI Dual Staining Kit | Suitable for Immunofluorescence(IF),BioReagent,Biological Stain,for microscopy,for fluorescence analysis,for cell culture | Dual viability staining (AO/PI); fluorescence microscopy assessment of cell status; cytotoxicity evaluation and culture quality monitoring | |
Annexin V-AF350 | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), 5 μL/test | Early apoptosis detection (Annexin V binding to externalized phosphatidylserine); fluorescence microscopy/flow cytometry apoptosis analysis (AF350 channel) | |
Annexin V-AF405 | Suitable for Immunofluorescence(IF), BioReagent, Suitable for microbiology, Biological Stain, 5 μL/test | Early apoptosis detection; fluorescence microscopy/flow cytometry apoptosis analysis (AF405 channel) | |
Annexin V-AF488 | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), 5 μL/test | Early apoptosis detection; fluorescence microscopy/flow cytometry apoptosis analysis (FITC/488 channel) | |
Annexin V-AF488/7-AAD Apoptosis Detection Kit | Suitable for Immunofluorescence(IF),BioReagent,Biological Stain,for microscopy,ready-to-use | Apoptosis phenotyping (discrimination of early apoptosis, late apoptosis, and necrosis); dual-staining analysis by flow cytometry or fluorescence microscopy (Annexin V + 7-AAD) | |
Annexin V-AF594 | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), 5 μL/test | Early apoptosis detection; fluorescence microscopy/flow cytometry apoptosis analysis (AF594 channel; suitable for multicolor panels) | |
Annexin V-AF647 | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), 5 μL/test | Early apoptosis detection; fluorescence microscopy/flow cytometry apoptosis analysis (far-red AF647 channel; suitable for multicolor panels) | |
Annexin V-AF647/7-AAD Apoptosis Detection Kit | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), ready-to-use | Apoptosis phenotyping (early/late apoptosis and necrosis); dual-staining analysis by flow cytometry or fluorescence microscopy (far-red Annexin V + 7-AAD) | |
Annexin V-AF680 | Suitable for Immunofluorescence(IF), BioReagent, Biological Stain, for microscopy, 5 μL/test | Early apoptosis detection; fluorescence microscopy/flow cytometry apoptosis analysis (AF680 channel) | |
Annexin V-AF750 | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), 5 μL/test | Early apoptosis detection; fluorescence microscopy/flow cytometry apoptosis analysis (near-infrared/AF750 channel) | |
Annexin V-APC | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), 5 μL/test | Early apoptosis detection; flow cytometry/fluorescence microscopy apoptosis analysis (APC channel) | |
Annexin V-APC/7-AAD Apoptosis Detection Kit | Bioactive, ready-to-use, Biological Stain, for microscopy, for fluorescence analysis | Apoptosis phenotyping (early/late apoptosis and necrosis); dual-staining analysis by flow cytometry or fluorescence microscopy (APC + 7-AAD) | |
Annexin V-APC/DAPI Apoptosis Detection Kit | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), ready-to-use | Apoptosis phenotyping with membrane integrity readout; multicolor apoptosis analysis by flow cytometry or fluorescence microscopy (APC + DAPI) | |
Annexin V-APC/PI Apoptosis Detection Kit | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF) | Apoptosis phenotyping (early/late apoptosis and necrosis); dual-staining analysis by flow cytometry or fluorescence microscopy (APC + PI) | |
Annexin V-Biotin | Suitable for Immunofluorescence(IF), BioReagent, Biological Stain, for microscopy, 5 μL/test | Early apoptosis detection; compatible with streptavidin-based fluorescent/enzymatic systems for signal amplification and multi-platform detection | |
Annexin V-Biotin/PI Apoptosis Detection Kit | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), ready-to-use | Apoptosis phenotyping (early/late apoptosis and necrosis); streptavidin–biotin system combined with PI for flow cytometry/microscopy analysis | |
Annexin V-Cy5 | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), 5 μL/test | Early apoptosis detection; fluorescence microscopy/flow cytometry apoptosis analysis (Cy5 far-red channel) | |
Annexin V-FITC | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), 5 μL/test | Early apoptosis detection; flow cytometry/fluorescence microscopy apoptosis analysis (FITC channel) | |
Annexin V-FITC/7-AAD Apoptosis Detection Kit | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), ready-to-use | Apoptosis phenotyping (early/late apoptosis and necrosis); dual-staining analysis by flow cytometry or fluorescence microscopy (FITC + 7-AAD) | |
Annexin V-FITC/PI Apoptosis Detection Kit | Suitable for Immunofluorescence(IF), BioReagent, Biological Stain, for microscopy | Apoptosis phenotyping (early/late apoptosis and necrosis); dual-staining analysis by flow cytometry or fluorescence microscopy (FITC + PI) | |
Annexin V-PE | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), 5 μL/test | Early apoptosis detection; flow cytometry/microscopy apoptosis analysis (PE channel; compatible with multicolor panels) | |
Annexin V-PE-Cy5 | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), 5 μL/test | Early apoptosis detection; multicolor flow cytometry apoptosis analysis (PE-Cy5 channel) | |
Annexin V-PE-Cy5/DAPI Apoptosis Detection Kit | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), ready-to-use | Apoptosis phenotyping with nucleic acid dye for membrane integrity discrimination; flow cytometry/microscopy multicolor analysis (PE-Cy5 + DAPI) | |
Annexin V-PE-Cy7 | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), 5 μL/test | Early apoptosis detection; multicolor flow cytometry apoptosis analysis (PE-Cy7 channel) | |
Annexin V-PE-Cy7/DAPI Apoptosis Detection Kit | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), ready-to-use | Apoptosis phenotyping (discrimination of early apoptosis, late apoptosis, and necrosis); flow cytometry/microscopy multicolor analysis (PE-Cy7 + DAPI) | |
Annexin V-PE-Cy7/7-AAD Apoptosis Detection Kit | Suitable for Immunofluorescence(IF),BioReagent,Biological Stain,for microscopy,ready-to-use | Apoptosis phenotyping (early/late apoptosis and necrosis); dual-staining analysis by flow cytometry/microscopy (PE-Cy7 + 7-AAD) | |
Annexin V-PE/7-AAD Apoptosis Detection Kit | BioReagent, Biological Stain, for microscopy, Suitable for Immunofluorescence(IF), ready-to-use | Apoptosis phenotyping (early/late apoptosis and necrosis); dual-staining analysis by flow cytometry/microscopy (PE + 7-AAD) | |
Annexin V-Pacific Blue | Suitable for Immunofluorescence(IF), BioReagent, Biological Stain, for microscopy, 5 μL/test | Early apoptosis detection; flow cytometry/fluorescence microscopy apoptosis analysis (Pacific Blue channel) | |
Hoechst 33258/PI Apoptosis Detection Kit | BioReagent,Biological Stain,for microscopy,ready-to-use | Apoptosis and nuclear morphology observation; Hoechst nuclear staining plus PI staining of membrane-compromised cells; fluorescence microscopy-based apoptosis phenotyping | |
Hoechst 33342/PI Apoptosis Detection Kit | BioReagent,Biological Stain,for microscopy,ready-to-use | Apoptosis and nuclear morphology observation; live-cell nuclear staining (Hoechst 33342) combined with PI to discriminate dead cells; fluorescence microscopy analysis | |
Neutral Red Staining Solution (for Live Cells) | BioReagent, Biological Stain, for microscopy, sterile | Live-cell lysosome/intracellular uptake staining; cell viability and cytotoxicity evaluation (Neutral Red Uptake, NRU); culture status monitoring | |
Cell Cycle and Apoptosis Detection Kit | BioReagent, for microscopy, Biological Stain, Suitable for Immunofluorescence(IF), for fluorescence analysis, for cell culture, ready-to-use, for DNA and RNA applications, sterile-filtered | Cell cycle analysis (quantification of DNA content); apoptosis detection and sub-G1 peak analysis; flow cytometry/fluorescence microscopy for DNA/RNA-related assays and proliferation assessment |
II. Cell Proliferation Assay (EdU)
Cell proliferation is a foundational metric for assessing cellular growth status, the effects of drug or genetic perturbations, and cell-cycle dynamics. The EdU approach interrogates nascent DNA synthesis: EdU is incorporated into replicating DNA as cells enter S phase, after which a click-chemistry reaction enables efficient and highly specific conjugation of a fluorescent moiety to the incorporated sites, allowing intuitive labeling and quantitative analysis of proliferating cells. This workflow is typically paired with fluorescence microscopy imaging or fluorescence analysis platforms, and is available in multiple fluorescence-channel formats to facilitate combination with multicolor experiments such as immunofluorescence while supporting signal separation.
【Principle】
(1) EdU is a thymidine analog that is incorporated into newly synthesized DNA strands during the DNA replication phase (S phase), thereby directly labeling DNA synthesis events.
(2) Using a bioorthogonal click-chemistry reaction, a fluorescent moiety can be efficiently and specifically conjugated to EdU-incorporated sites, enabling fluorescence visualization and quantitative detection of proliferating cells.
(3) The fraction of EdU-positive cells represents the proportion of cells undergoing DNA synthesis within the defined pulse-labeling window; the distribution of signal intensity can reflect differences in DNA synthesis activity.
(4) When combined with DNA content staining, EdU signals can be interpreted in a cell-cycle context, assisting in identifying points of cell-cycle arrest and phenotypes associated with replication stress.
【Advantages】
(1) The readout corresponds directly to DNA synthesis, and is therefore closer to the core process of “proliferative progression” than metabolic proxies, helping distinguish the relative contributions of proliferation inhibition versus increased cell death to changes in total cell abundance.
(2) Compatible with fluorescence microscopy and flow cytometry, enabling single-cell quantification and providing spatial distribution information to support morphological and localization analyses.
(3) Available in multiple fluorescence-channel variants, facilitating signal separation and multicolor panel design in combination with immunofluorescence or other labeling systems.
(4) Broadly applicable to pharmacological screening, gene function studies, cell-cycle regulation research, and investigations of replication stress.
【Limitations and Notes】
(1) Fixation and permeabilization are typically required to perform the click-chemistry reaction. When integrating with assays that rely on live-cell membrane events, workflow coupling may reduce interpretability; in practice, parallel-sample designs are often adopted.
(2) The pulse-labeling duration determines the statistical meaning of the metric. Different time windows correspond to distinct interpretations (e.g., instantaneous S-phase fraction versus cumulative replication events); this should be explicitly defined and kept consistent in experimental design.
(3) Multicolor detection carries a risk of spectral bleed-through. Use single-stain controls and apply compensation (flow cytometry) or match filter sets and exposure parameters (imaging) to stabilize the positivity threshold.
(4) Treatment conditions may induce S-phase accumulation, replication fork stalling, or DNA damage responses, altering EdU labeling patterns. Interpret EdU results jointly with cell-cycle structure and cell-death phenotyping to avoid oversimplifying replication-stress phenotypes as merely “increased/decreased proliferation.”
【Aladdin-related Products】
Catalog No. | Product Name | Grade and Purity | Applications |
EdU Cell Proliferation Detection Kit (6-FAM) | BioReagent, Biological Stain, for microscopy, for fluorescence analysis | Cell proliferation assessment (DNA synthesis/S-phase labeling via EdU incorporation); quantitative determination of proliferating cell fraction by fluorescence microscopy imaging; evaluation of proliferation changes following drug or gene perturbation and cell cycle–related studies | |
EdU Cell Proliferation Detection Kit (AF488) | Bioactive, Biological Stain, for microscopy, for fluorescence analysis | Cell proliferation assessment (EdU labeling of nascent DNA for identification of S-phase cells); quantitative proliferation analysis on fluorescence microscopy and fluorescence analysis platforms; tumor cell growth studies, pharmacological efficacy screening, and phenotypic assessment of cell viability/proliferation | |
EdU Cell Proliferation Detection Kit (AF647) | BioReagent, Biological Stain, for microscopy, for fluorescence analysis | Cell proliferation assessment (EdU incorporation into newly synthesized DNA); far-red channel imaging/detection to facilitate multicolor panel design; proliferation imaging and comparative analysis across treatment groups in tissue sections or adherent cell preparations |
III. Metabolic/Enzymatic Colorimetric Assays
Metabolic/enzymatic colorimetric assays comprise a class of “activity-indicating” methods that leverage intracellular reductase systems in cells or tissues (in particular, dehydrogenase activity). TTC is commonly used for viability interpretation at the tissue level: metabolically active cells reduce TTC to generate a colored product, enabling contrast visualization between viable tissue and ischemic/necrotic regions. In contrast, water-soluble tetrazolium salts are more frequently used for quantitative assessment of cellular metabolism/viability, relying on metabolic reduction to form soluble chromogenic products that are compatible with microplate absorbance readout and high-throughput screening. These methods are relatively straightforward to implement and broadly adaptable, and are widely applied to evaluate cell viability/proliferation, compare cytotoxicity across conditions, and determine viability and injury extent in models such as ischemic damage.
【Principle】
(1) Intracellular reductase systems (e.g., dehydrogenases) reduce tetrazolium substrates to colored products; the readout reflects the integrated metabolic reducing capacity of the cell population over a defined time window.
(2) Water-soluble tetrazolium systems generate soluble chromogenic products suitable for microplate-based readout, enabling high-throughput quantitative comparison of cell viability/toxicity and treatment effects.
(3) TTC is commonly applied to tissue sections; metabolically active tissue reduces TTC to yield color differences, thereby supporting comparative interpretation and extent estimation of viable versus necrotic/infarct regions.
(4) Signals are jointly influenced by multiple factors—including mitochondrial function, glycolytic flux, availability of reducing equivalents, cell density, and culture conditions—and therefore represent an integrated output metric of metabolic phenotype.
【Advantages】
(1) High throughput and operational efficiency, suitable for concentration gradients, time-course gradients, and large-scale condition screening, and amenable to kinetic monitoring.
(2) Procedures are readily standardized with good within-batch consistency and statistical usability, supporting quantitative comparisons between treatment groups.
(3) Relatively sensitive to early functional metabolic inhibition, facilitating detection of stress responses or pathway suppression before overt structural cell death becomes apparent.
(4) In tissue models (TTC), offers an intuitive spatial contrast advantage, enabling visual evaluation of injury extent or necrotic region distribution.
【Limitations and Notes】
(1) Metabolic colorimetric readouts are not equivalent to cell number or survival fraction; metabolic reprogramming can alter signals with limited changes in death modality. Parallel assays for apoptosis/proliferation are recommended to improve interpretability.
(2) Color, turbidity, absorbance characteristics, or intrinsic chemical reducing activity of treatments may introduce systematic interference. Include “treatment + medium, no cells” correction wells and perform background subtraction.
(3) Incubation time should be controlled within the linear range; excessively long incubation may cause saturation, whereas overly short incubation may yield insufficient signal-to-noise. Optimize the readout window via pilot experiments.
(4) Seeding uniformity and edge-well evaporation can substantially amplify well-to-well variance. Optimize plate layout, increase replicates, and standardize handling to reduce systematic error.
【Aladdin-related Products】
Catalog No. | Product Name | CAS No. | Grade and Purity | Applications |
TTC Staining Solution (1%) | 298-96-4 | BioReagent, Biological Stain, for microscopy, 1% | Tissue viability / ischemic necrosis assessment (TTC reduction reaction): commonly used on myocardial or brain tissue sections to distinguish viable from infarcted regions; indicates mitochondrial dehydrogenase activity and enables quantification of necrotic extent; applied to evaluation of ischemia–reperfusion injury in animal models. | |
TTC Staining Solution (2%) | 298-96-4 | BioReagent, Biological Stain, for microscopy, 2% | TTC tissue viability staining (higher-concentration formulation): used to provide clear contrast between infarct/necrotic regions and viable tissue; lesion area measurement and tissue viability assessment in myocardial infarction and cerebral infarction models. | |
Water soluble tetrazolium-11 |
| Biological Stain, Biochemical | Water-soluble tetrazolium salt substrate for activity/metabolic assays: dehydrogenase activity indicator for colorimetric determination of cell viability/proliferation; compatible with high-throughput formats such as 96-well plates (produces a soluble formazan product for convenient absorbance readout). | |
Sodium 4-[3-(4-iodophenyl)-2-(2,4-dinitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate | 161617-45-4 | Biological Stain, Biochemical | Water-soluble tetrazolium salt (WST class) for cell viability/toxicity and proliferation assays: based on metabolic reduction to generate a soluble formazan for colorimetric quantification; suitable for drug screening and cell function evaluation. | |
Water-soluble tetrazolium-5 | 178925-55-8 | Biological Stain, Biochemical | Water-soluble tetrazolium salt (WST class) substrate for cell viability/metabolic assays: colorimetric quantification of cytotoxicity and proliferation; suitable for high-throughput experiments and kinetic monitoring (soluble product enables convenient readout). |
Cell function assays are evolving toward integrated multiparametric readouts, higher analytical sensitivity, and higher throughput. Apoptosis detection has advanced beyond simple phenotypic discrimination to mechanistic interrogation; when combined with caspase activity measurements and apoptosis signaling pathway analyses, these approaches provide more precise tools for studying disease mechanisms. Proliferation analysis is increasingly integrated with flow cytometry and single-cell sequencing, enabling characterization of gene-expression signatures in proliferating cell populations. Metabolic activity measurements are also being coupled with nanotechnology and imaging modalities to develop noninvasive, in vivo–level assays, opening new avenues for clinical response evaluation. Continued innovation in these technologies will further promote the deep integration of fundamental life-science research with clinical translational applications.
Aladdin: https://www.aladdinsci.com/